Thought Leadership
Beyond the Merits: Generic Company Defense Strategies
June 29, 2018
Joshua Reisberg
Pharmaceutical Executive

Pharmaceutical Executive published Axinn counsel Josh Reisberg's article, "Beyond the Merits: Generic Company Defense Strategies."

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.